Cyclo (RLsKDK)
Cyclo (RLsKDK) (BK-1361) is a specific inhibitor of metalloproteinase ADAM8 with an IC50 value of 182 nM. cyclo (RLsKDK) has potential applications in inflammatory diseases and cancer[1].
Product Specifications
CAS Number
1975145-82-4
Product Name Alternative
BK-1361
UNSPSC
12352209
Target
MMP
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyclo-rlskdk.html
Purity
98.85
Solubility
DMSO : 3.33 mg/mL (ultrasonic)
Smiles
N=C(N)NCCC[C@@H](C(N[C@H](C(N[C@@H](C(N[C@H]1CCCCN)=O)CO)=O)CC(C)C)=O)NC([C@@H](NC([C@@H](NC1=O)CC(O)=O)=O)CCCCN)=O
Molecular Formula
C31H57N11O9
Molecular Weight
727.85
References & Citations
[1]Yim V, et al. Synthesis and biological evaluation of analogues of the potent ADAM8 inhibitor cyclo (RLsKDK) for the treatment of inflammatory diseases and cancer metastasis. Bioorg Med Chem. 2016 Sep 15;24 (18) :4032-4037. |[2]Schlomann U, et al. ADAM8 as a drug target in pancreatic cancer. Nat Commun. 2015 Jan 28;6:6175.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog